EurekAlert!

ECOG-ACRIN discovers a simple blood test may predict recurrence of breast cancer

A simple blood test that detects tumor cells circulating in the blood shows promise as a new way to predict high or low risk of a breast cancer relapse. This is according to data presented today at ...
EurekAlert!

ECOG-ACRIN and Caris Life Sciences partner to interrogate landmark TAILORx breast cancer trial

ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and Caris Life Sciences ® (Caris) announced today a multi-year research collaboration wherein Caris is pairing its highly sophisticated and comprehensive ...
ascopubs.org

Randomized trial of web-based genetic education versus usual care in advanced cancer patients undergoing tumor genetic testing: Results from the ECOG-ACRIN NCI Community ...

The BRCA founder outreach study: Initial results of a digital health model. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include a full text component.
PharmiWeb

Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker ...

Foundation Medicine remains one of the chief contributors to ComboMATCH, the largest of its kind initiative to test effectiveness of biomarker-targeted cancer treatment combinations BOSTON--(BUSINESS ...